National Guideline Clearinghouse | Guidelines by Topic: Prostatic Neoplasms

National Guideline Clearinghouse | Guidelines by Topic: Prostatic Neoplasms

Guidelines by Topic

Disease/Condition > Diseases (2224) > Neoplasms (575) > Neoplasms by Site (427) > Urogenital Neoplasms (118) > Genital Neoplasms, Male (49) >

Prostatic Neoplasms (40)

Narrow:

Prostatic Neoplasms, Castration-Resistant (2)

1-20 of 40   Next >
1. Recommendations on screening for prostate cancer with the prostate-specific antigen test. 1994 Jun (revised 2014 Nov 4). NGC:010592 Canadian Task Force on Preventive Health Care - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
2. Systemic therapy in men with metastatic castration-resistant prostate cancer: American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline. 2014 Oct 20. NGC:010623 American Society of Clinical Oncology - Medical Specialty Society; Cancer Care Ontario - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
3. Enzalutamide for metastatic hormone-relapsed prostate cancer previously treated with a docetaxel-containing regimen. 2014 Jul. NGC:010496 National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
4. Castration-resistant prostate cancer: AUA guideline. 2013 Apr (revised 2014 Apr). [NGC Update Pending]NGC:010421 American Urological Association Education and Research, Inc. - Medical Specialty Society. View all guidelines by thedeveloper(s) Compare Selected
5. ACR Appropriateness Criteria® postradical prostatectomy irradiation in prostate cancer. 1996 (revised 2014). NGC:010470 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
6. Prostate cancer: diagnosis and treatment. 2008 Feb (revised 2014 Jan). NGC:010205 National Collaborating Centre for Cancer - National Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s) Compare Selected
7. Prostate cancer. 2011 Jan (revised 2013 Sep). NGC:010265 CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
8. Adjuvant and salvage radiotherapy after prostatectomy: ASTRO/AUA guideline. 2013 Apr. NGC:009907 American Society for Radiation Oncology - Professional Association; American Urological Association Education and Research, Inc. - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
9. Early detection of prostate cancer: AUA guideline. 2013 Apr. NGC:009913 American Urological Association Education and Research, Inc. - Medical Specialty Society. View all guidelines by thedeveloper(s)  Compare Selected
10. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians. 2013 May 21. NGC:009823 American College of Physicians - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
11. Adult preventive services (ages 50 - 65+). 2005 Jul (revised 2013 Mar). NGC:009929 Michigan Quality Improvement Consortium - Professional Association. View all guidelines by the developer(s) Compare Selected
12. ACR Appropriateness Criteria® definitive external-beam irradiation in stage T1 and T2 prostate cancer.1996 (revised 2013). NGC:010181 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
13. ACR Appropriateness Criteria® high-dose-rate brachytherapy for prostate cancer. 2013. NGC:010182 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
14. Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer. 2012 Oct 31. NGC:010223 Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s) Compare Selected
15. Cancer screening. 2004 May (revised 2012 Oct). NGC:009352 University of Michigan Health System - Academic Institution. View all guidelines by the developer(s) Compare Selected
16. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. 1996 (revised 2012 Jul 17). NGC:009101 U.S. Preventive Services Task Force - Independent Expert Panel. View all guidelines by the developer(s)  Compare Selected
17. Risk reduction of prostate cancer with drugs or nutritional supplements. 2012 May 17. NGC:009863 Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s) Compare Selected
18. ACR Appropriateness Criteria® prostate cancer—pretreatment detection, staging and surveillance. 2005 (revised 2012). NGC:009671 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
19. Early detection of cancers. In: Guidelines for preventive activities in general practice, 8th edition. 2012. NGC:009647 Royal Australian College of General Practitioners - Professional Association. View all guidelines by the developer(s) Compare Selected
20. National Institutes of Health State-of-the-Science Conference statement: role of active surveillance in the management of men with localized prostate cancer. 2011 Dec. NGC:009139 National Institutes of Health Consensus Development Conference - Independent Expert Panel. View all guidelines by the developer(s) Compare Selected
1-20 of 40   Next >